XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Revenues:            
Total revenues $ 1,537,000 $ 1,298,000 $ 3,829,000 $ 3,677,000 $ 4,454,000 $ 4,997,000
Operating expenses :            
Cost of revenues 1,032,000 818,000 2,136,000 1,996,000 2,174,000 3,969,000
Research and development 24,000 15,000 40,000 55,000 64,000 15,000
Gain on sale of Verdeca         0 (1,138,000)
Impairment of intangible assets         0 141,000
Change in fair value of contingent consideration         0 (70,000)
Gain on sale of property and equipment         (29,000) (314,000)
Gain on sale of intangible assets 0 0 (4,000,000) 0    
Impairment of property and equipment 0 0 36,000 0 0 160,000
Impairment of Right-Of-Use Asset         113,000 0
Selling, general and administrative 2,241,000 1,862,000 6,986,000 6,535,000 8,234,000 9,221,000
Total operating expenses 3,297,000 2,695,000 5,198,000 8,586,000 10,556,000 11,984,000
Loss from continuing operations (1,760,000) (1,397,000) (1,369,000) (4,909,000) (6,102,000) (6,987,000)
Interest income 233,000 133,000 428,000 538,000 695,000 289,000
Other income , net 15,000 17,000 168,000 36,000 48,000 9,000
Valuation loss on March 2023 PIPE 0 0 0 (6,076,000) (6,076,000) 0
Change in fair value of common stock warrant and option liabilities 330,000 608,000 493,000 5,965,000 6,544,000 3,209,000
Issuance and offering costs allocated to liability classified options 0 0 0 (430,000) (430,000) (314,000)
Net loss from continuing operations before income taxes (1,182,000) (639,000) (280,000) (4,876,000) (5,321,000) (3,794,000)
Income tax provision 0 0 0 (1,000) (8,000) (14,000)
Net loss from continuing operations (1,182,000) (639,000) (280,000) (4,877,000) (5,329,000) (3,808,000)
Net loss (1,612,000) (2,567,000) (2,974,000) (11,133,000) (13,986,000) (15,612,000)
Net loss attributable to non-controlling interest 0 0 0 (5,000) (5,000) (236,000)
Net loss attributable to common stockholders $ (1,612,000) $ (2,567,000) $ (2,974,000) $ (11,128,000) $ (13,981,000) $ (15,376,000)
Net loss per share attributable to common stockholders:            
Basic net loss per share attributable to common stockholders from continuing operations $ (0.87) $ (0.47) $ (0.21) $ (4.08) $ (4.3) $ (5.96)
Diluted net loss per share attributable to common stockholders from continuing operations (0.87) (0.47) (0.21) (4.08) (4.3) (5.96)
Basic net loss per share attributable to common stockholders from discontinued operations (0.32) (1.42) (1.98) (5.24) $ (7) $ (19.69)
Net loss per basic share attributable to common stockholders (1.18) (1.89) (2.18) (9.31)    
Net loss per diluted share attributable to common stockholders $ (1.18) $ (1.89) $ (2.18) $ (9.31)    
Weighted-average number of shares used in per share calculations:            
Weighted average shares - Basic 1,363,753 1,359,511 1,362,754 1,195,354 1,236,934 599,389
Weighted average shares - Diluted 1,363,753 1,359,511 1,362,754 1,195,354 1,236,934 599,389
Other comprehensive income (loss), net of tax            
Unrealized gains on available-for-sale securities $ 36,000 $ 66,000 $ 117,000 $ 87,000 $ 101,000 $ 0
Reclassification adjustment for gains on available-for-sale securities included in net loss 0 0 (111,000) 0    
Other comprehensive income         101,000 0
Change in unrealized gains on available-for-sale securities 36,000 66,000 6,000 87,000    
Comprehensive loss (1,576,000) (2,501,000) (2,968,000) (11,041,000) (13,880,000) (15,376,000)
Body Care            
Operating expenses :            
Net loss from discontinued operations 0 (83,000) 0 (591,000) (821,000) (4,784,000)
GoodWheat            
Operating expenses :            
Net loss from discontinued operations (430,000) (1,845,000) (2,694,000) (5,665,000) (7,836,000) (7,020,000)
Product            
Revenues:            
Total revenues 1,537,000 1,298,000 3,829,000 3,667,000 4,437,000 4,001,000
Royalty            
Revenues:            
Total revenues         0 117,000
License            
Revenues:            
Total revenues $ 0 $ 0 $ 0 $ 10,000 $ 17,000 $ 879,000